Biocross to participate in the 8th International Meeting on Biotechnology, Biospain 2016, which takes place in Bilbao (Vizcaya), September 28–30, 2016.
Biospain has become the main scientific, social, commercial, and industrial meeting point of the biotechnological sector and the primary platform for the international presentation of advances in Spanish biotechnology.
Biocross will present its project in the investor’s forum with the objective of attracting additional funding to complete the ApoE ε4 test, including scale-up, CE marking and FDA submission, and the development of the AD dementia test service, including a follow-on study. Through the organization of bilateral meetings between companies Biocross seeks to foster partnerships between companies that are interested in licensing or acquiring tests and to offer its test as an enrichment tool for clinical trials.
Date/Time: 11 a.m, Thursday, September 29, 2016.
Location: Room A, Bilbao Exhibition Centre (BEC), Barakaldo (Bilbao), Spain.